Anakinra Rescue Treatment for Moderate Asthma Attacks
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether a medication called anakinra can help treat asthma attacks in people who already take daily asthma controller medications. Anakinra works by reducing inflammation in the airways, and researchers want to see if it can help people recover faster from moderate asthma flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have persistent asthma diagnosed by a doctor and take daily controller medication (like an inhaled corticosteroid)
- You've had at least one asthma attack requiring oral steroid medication in the past year
- You have moderate asthma severity (AIRQ score greater than 2)
- You are willing and able to self-inject medication and use reliable birth control if sexually active
- You have not had a serious asthma attack requiring a breathing tube in the past 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a drug called anakinra can improve how your heart responds to inotrope therapy (medicines that help your heart pump). It is for people with advanced heart failure who are already on a steady dose of these medicines and have signs of inflammation. The goal is to see if blocking inflammation helps your heart work better.
This trial tests whether a medicine called anakinra can help children with acute myocarditis (heart inflammation) in the ICU. It aims to see if the drug reduces heart damage and improves recovery.
This Phase 2/3 trial studies whether anakinra can improve ongoing (post-acute) COVID-19 symptoms lasting for more than two months. It mainly looks for better safety and symptom improvement in people with specific inflammation and lung-related findings.
This trial tests different doses and ways of giving a medicine called anakinra to preterm babies. It aims to find the safest and most effective dose to help reduce inflammation.
This trial tests an anti-inflammatory drug (anakinra) in people whose inner-ear hearing problems have not improved with steroid treatment. It aims to reduce worsening hearing caused by autoimmune inner ear disease or difficult-to-control Meniere’s disease.
This study tests a new injected medicine (RC1416) for people with moderate-to-severe asthma that is not well controlled with daily inhalers. It may help reduce asthma attacks and improve breathing.
Hear when a new Asthma (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.